BAIT
                         FNTA
FPTA, PGGT1A, PTAR2
                         farnesyltransferase, CAAX box, alpha
 
                         
                         
                         GO Process (10)
GO Function (5)
GO Component (5)
Gene Ontology Biological Process
- apoptotic process [TAS]
 - cellular component disassembly involved in execution phase of apoptosis [TAS]
 - phototransduction, visible light [TAS]
 - positive regulation of deacetylase activity [IDA]
 - positive regulation of tubulin deacetylation [IDA]
 - protein farnesylation [IDA]
 - protein geranylgeranylation [IDA]
 - regulation of rhodopsin mediated signaling pathway [TAS]
 - rhodopsin mediated signaling pathway [TAS]
 - transforming growth factor beta receptor signaling pathway [TAS]
 
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
                     PREY
                         XRCC3
CMM6
                         X-ray repair complementing defective repair in Chinese hamster cells 3
 
                         
                         
                         GO Process (8)
GO Function (3)
GO Component (6)
Gene Ontology Biological Process
- DNA catabolic process, endonucleolytic [IMP]
 - DNA recombination [TAS]
 - DNA repair [IGI]
 - cellular response to DNA damage stimulus [TAS]
 - double-strand break repair via homologous recombination [IMP]
 - positive regulation of mitotic cell cycle spindle assembly checkpoint [IMP]
 - regulation of centrosome duplication [IMP]
 - resolution of mitotic recombination intermediates [IMP]
 
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
                     Synthetic Lethality
A genetic interaction is inferred when mutations or deletions in separate genes, each of which alone causes a minimal phenotype, result in lethality when combined in the same cell under a given condition.
Publication
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
An emerging therapeutic strategy for cancer is to induce selective lethality in a tumor by exploiting interactions between its driving mutations and specific drug targets. Here we use a multi-species approach to develop a resource of synthetic lethal interactions relevant to cancer therapy. First, we screen in yeast ∼169,000 potential interactions among orthologs of human tumor suppressor genes (TSG) and ... [more]
Mol. Cell Aug. 04, 2016; 63(3);514-25 [Pubmed: 27453043]
 
             Throughput
- High Throughput
 
Ontology Terms
- growth abnormality (HP:0001507) [hela cell (BTO:0000567)]
 
Additional Notes
- Chemo-genetic screen with siRNAs
 - Drug target: RABGGTB,FNTA double mutant
 - Drug: tipifarnib
 - HeLa cervical cancer cell line
 
Curated By
- BioGRID